Benefits & Considerations Potential Benefits: Greater total fat loss Reduced hunger and cravings Possible metabolic improvements beyond semaglutide May help maintain results long-term Considerations: Not yet FDA-approved Side effects may overlap (nausea, constipation, fatigue) Long-term safety data still limited Why This Matters for the Future of Weight Management The combination of Retatrutide + Cagrilintide represents the next evolution of metabolic pharmacology, one that treats obesity like the complex, multi-hormonal disease it is
Certain side effects have been reported in clinical trials, including gastrointestinal discomfort and allergic reactions
Y.et al (2019b)
In laboratory and pre-clinical settings, DSIP has been studied as a uniquely multifunctional endogenous regulatory neuropeptide across sleep, stress, neuroendocrine, neuroprotection, and geroprotective research applications: Sleep biology delta-wave SWS promotion, sleep homeostasis modulation, sleep efficiency and sleep latency research Sleep EEG research delta-wave induction, SWS vs REM sleep architecture, and sleep stage analysis via polysomnography Sleep neuromodulator pharmacology DSIP vs sedatives and hypnotics
